ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 10-Q:季度報表
ReShape Lifesciences | S-3:特定交易註冊聲明
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 10-K:年度報表
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | DEF 14A:股東委託書決議
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | SC 13G:超過5%持股股東披露文件-Yair Schneid(10.525%)
ReShape Lifesciences | 3:首次持股聲明-股東 Schneid Yair
ReShape Lifesciences | PRE 14A:並購重組委托聲明
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences:2023財年三季報
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 4:持股變動聲明-首席財務官 STANKOVICH THOMAS
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 8-K:重大事件
ReShape Lifesciences | 424B4:募資說明書
暫無數據